Cardiovascular Risk Modification in Childhood: Hyperlipidemia
نویسندگان
چکیده
منابع مشابه
Cardiovascular risk factors in childhood.
It is regrettable that although the incidence of fatal coronary heart disease on the other side of the Atlantic and in Australia is falling, the toll here, even if not increasing at the great pace of the 'fifties and 'sixties, is only just beginning to level off. Few of us can afford to be complacent, and we as paediatricians have a duty to sow the seeds of longevity in our patients. For these ...
متن کاملHyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.
Guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) and the U.K. National Institute for Health and Care Excellence (NICE) indicate that lipid-lowering drugs have benefit for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) events. The evidence is strongest for statins. ACC/AHA, NICE, and U.S. Preventive Services Task Force (U...
متن کاملLifetime risk: childhood obesity and cardiovascular risk.
In a recent report, the worldwide prevalence of childhood obesity was estimated to have increased by 47% between 1980 and 2013. As a result, substantial concerns have been raised about the future burden of cardiovascular (CV) disease that could ensue. The purpose of this review is to summarize and interpret (i) the evidence linking early life obesity with adverse changes in CV structure and fun...
متن کاملLipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects
Lipoprotein (a) [Lp(a)] is a modified LDL particle with an additional apolipoprotein [apo(a)] protein covalently attached by a thioester bond. Multiple isoforms of apo(a) exist that are genetically determined by differences in the number of Kringle-IV type-2 repeats encoded by the LPA gene. Elevated plasma Lp(a) is an independent risk factor for cardiovascular disease.The phenotypic diversity o...
متن کاملPostprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and triglycerides concentrations and several of them routinely reduce CVD risk. However, in contemporar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Mayo Clinic Proceedings
سال: 1986
ISSN: 0025-6196
DOI: 10.1016/s0025-6196(12)62616-0